Three-pathway combination for glutathione biosynthesis in Saccharomyces cerevisiae by Liang Tang et al.




for glutathione biosynthesis in Saccharomyces 
cerevisiae
Liang Tang1†, Weiwei Wang3†, Wenlong Zhou2, Kai Cheng3, Yan Yang1, Minzhi Liu2, Kedi Cheng2 
and Wei Wang1,2*
Abstract 
Background: Glutathione (GSH), a pivotal non-protein thiol, can be biosynthesized through three pathways in differ-
ent organisms: (1) two consecutive enzymatic reactions catalyzed by γ-glutamylcysteine synthetase (Gsh1 or GshA) 
and glutathione synthetase (Gsh2 or GshB); (2) a bifunctional γ-glutamylcysteine synthetase/glutathione synthetase 
(GshF); (3) an alternative condensation of γ-glutamyl phosphate synthesized by γ-glutamyl kinase (Pro1 or ProB) 
with cysteine to form γ-glutamylcysteine which was further conjugated to glycine by glutathione synthetase. The 
Gsh1 and Gsh2 of conventional GSH biosynthetic pathway or the bifunctional GshF reported previously have been 
independently modulated for GSH production. This study developed a novel three-pathway combination method to 
improve GSH production in Saccharomyces cerevisiae.
Results: A bifunctional enzyme GshF of Actinobacillus pleuropneumoniae was functionally expressed in S. cerevisiae 
and Pro1 in proline biosynthetic pathway was exploited for improving GSH yield. Moreover, two fusion proteins Gsh2-
Gsh1 and Pro1-GshB were constructed to increase the two-step coupling efficiency of GSH synthesis by mimicking 
the native domain fusion of GshF. The engineered strain W303-1b/FGP with three biosynthetic pathways presented 
the highest GSH concentration (216.50 mg/L) and GSH production of W303-1b/FGP was further improved by 61.37 % 
when amino acid precursors (5 mM glutamic acid, 5 mM cysteine and 5 mM glycine) were fed in shake flask cultures. 
In batch culture process, the recombinant strain W303-1b/FGP also kept high efficiency in GSH production and 
reached an intracellular GSH content of 2.27 % after 24-h fermentation.
Conclusions: The engineered strains harbouring three GSH pathways displayed higher GSH producing capacity than 
those with individually modulated pathways. Three-pathway combinatorial biosynthesis of GSH promises more effec-
tive industrial production of GSH using S. cerevisiae.
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Background
Glutathione (γ-l-glutamyl-l-cysteinylglycine, GSH) is an 
intracellular redox-active tripeptide thiol found in living 
organisms [1, 2]. The free sulfhydryl moiety of cysteine 
residue contributes to a wide variety of biological activi-
ties, such as anti-oxidization [3], detoxification [4, 5] and 
immune regulation [6], etc. GSH has been widely used in 
pharmaceutical, food and cosmetic industries.
GSH is primarily synthesized intracellularly 
through two consecutive reactions catalyzed by 
γ-glutamylcysteine synthetase (Gsh1 in eukaryotes 
and GshA in prokaryotes, encoded by GSH1 and gshA, 
respectively) and glutathione synthetase (Gsh2 in eukary-
otes and GshB in prokaryotes, encoded by GSH2 and 
gshB, respectively). Gsh1 catalyzes the formation of 
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γ-glutamylcysteine (γ-GC), which is subsequently con-
jugated to glycine by Gsh2 to form GSH. The activity of 
Gsh1 could be physiologically feedback-inhibited by GSH 
to avoid over-accumulation of GSH [7]. However, many 
organisms without Gsh1 or Gsh2 were reported to have 
the ability to produce GSH, which suggests that they may 
have a different pathway for generation of GSH. Recently, 
a novel bifunctional enzyme GshF (encoded by gshF) 
found in some Gram-positive bacteria such as: Listeria 
monocytogenes, Streptococcus agalactiae and Pasteurella 
multocida, was able to perform complete synthesis of 
GSH [8–11]. In other studies, compensatory pathway for 
GSH synthesis was characterized in yeast and Escherichia 
coli that lack Gsh1 and GshA [12, 13]. γ-glutamyl kinase 
(GK) encoded by PRO1 in eukaryotes or proB in prokary-
otes, the first enzyme in proline biosynthetic pathway, 
catalyzes the formation of intermediate γ-glutamyl phos-
phate, which if accumulated could partially react with 
cysteine to generate γ-GC, and then Gsh2 adds glycine 
to γ-GC to form GSH. Different biosynthetic pathways of 
GSH are as shown in Fig. 1 and referred as G pathway, F 
pathway and P pathway.
To date, GSH is mainly produced via fermentation. 
Yeasts, usually S. cerevisiae and Candida utilis, are more 
commonly used in industrial scale GSH production. GSH 
contents of the wild type (wt) yeasts are typically in the 
range of 0.1–1  %. The most successful strategy toward 
obtaining GSH overproducing strains was classical selec-
tion which resulted in GSH contents of 3–5 % [14]. Along 
with the identification and characterization of genes 
involved in GSH metabolism, many genetic engineer-
ing strategy studies have been conducted in an effort to 
increase GSH production using various model micro-
organisms. The reported GSH contents in genetically 
engineering strains ranged from 1 to 2 % in the absence 
of amino acid precursors [15–22]. Genetic manipula-
tion of the GSH biosynthetic pathway has been proved 
to be an effective method to produce GSH and provides 
a platform for further improvement. In previous reports, 
single modulation of G pathway and F pathway for GSH 
production could achieve GSH contents of 1.5–1.7 % [19, 
22] (Table  1). Besides, many efforts have been focused 
on medium optimization and process control to enhance 
GSH production, in particular introduction of amino 
acid precursors during GSH fermentation [23, 24].
Although genetic manipulations of a single pathway 
have increased GSH production of engineered strains, 
discovering how to further improve GSH production is 
still a real challenge for us. In this study, we focused on 
direct modulation of the GSH biosynthetic pathway via 
a method of three-pathway combination. Two artificially 
recombinant enzymes glutathione synthetase-linker-γ-
glutamylcysteine synthetase fusion protein (Gsh2-Gsh1) 
from S. cerevisiae, γ-glutamyl kinase-linker-glutathione 
synthetase hybrid (Pro1-GshB) from S. cerevisiae and E. 
coli and a resynthesized GshF of Actinobacillus pleuro-
pneumoniae were introduced into S. cerevisiae genome 
via independent or combinatorial genetic integration. 
The overexpression of genes from different pathways 
and synthetic capacities of GSH of different engineered 
strains were investigated. The data demonstrated that 
three-pathway combination was superior to single-path-
way for synthesis of GSH.
Results
Activity analysis of GshF from A. pleuropneumoniae 
expressed under the control of different promoters in S. 
cerevisiae
To examine the activity of codon-conformed A. pleuro-
pneumoniae GshF in S. cerevisiae and evaluate effect of 
Fig. 1 Biosynthetic pathways of GSH. G pathway, Gsh1 catalyzes the reaction between glutamic acid and cysteine to form γ-GC, which is subse-
quently conjugated to glycine by Gsh2 to synthesize GSH. F pathway, GshF accounts for Gsh1 and Gsh2 activities and carries out complete synthe-
sis of GSH. P pathway, Pro1 converts glutamate to γ-glutamyl phosphate, which reacts with cysteine to generate γ-GC, and then Gsh2 adds glycine 
to γ-GC to form GSH
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promoter strength on its activity, four δ DNA-medi-
ated integrative expression vectors pδGAPg-gshF, 
pδGAP′g-gshF, pδGAL1g-gshF and pδPGK1g-gshF 
were constructed, in which the gshF gene was driven by 
glyceraldehyde-3-phosphate dehydrogenase promoter 
(GAP) of S. cerevisiae, GAP promoter from Pichia pas-
toris (GAP′), galactokinase promoter (GAL1) of S. cerevi-
siae and phosphoglycerate kinase promoter (PGK1) of S. 
cerevisiae, respectively. S. cerevisiae W303-1b cells were 
transformed with the linearized recombinant plasmids to 
obtain engineered strains W303-1b/F/GAP, W303-1b/F/
GAP′, W303-1b/F/GAL1 and W303-1b/F/PGK1. The 
plasmids and strains constructed in the present study are 
listed in Table 2. GshF activities and promoter strengths 
could be determined by GSH concentrations of the engi-
neered strains in shake flask cultures.
GSH production in the engineered strains together 
with host strain W303-1b was compared as shown in 
Fig. 2. The four engineered strains conferred higher GSH 
concentrations than the parental strain. Among them, 
W303-1b/F/GAP (abbreviated to W303-1b/F in the fol-
lowing sections) produced higher intracellular GSH 
levels; the highest concentration was achieved after fer-
mentation for 48–60 h. This result indicated that A. pleu-
ropneumoniae GshF was active for GSH synthesis in S. 
cerevisiae. In addition, differences in synthetic capaci-
ties of GSH were considered to be directly related to the 
strengths of different promoters, thus GAP promoter of 
S. cerevisiae was utilized to keep uniform expression of 
each construct in this work.
Active GK for GSH biosynthesis in S. cerevisiae W303‑1b
In the cells lacking Gsh1-dependent biosynthetic path-
way of GSH, it was found that γ-glutamyl phosphate is 
a common precursor shared by proline and GSH biosyn-
thetic pathways. Thus, biosynthesis of proline could be 
partially diverted toward GSH production via γ-glutamyl 
phosphate (Fig. 1) and GK may play a central role in the 
alternative pathway.
Preliminary experiments had proved in  vitro activ-
ity of GK for formation of intermediate γ-GC (data not 
shown). For the purpose of exploiting an active GK for 
biosynthesis of GSH in S. cerevisiae W303-1b, plasmids 
pΔgsh1h, pΔgsh1h-pro1 and pΔgsh1h-proB were con-
structed. With the homologous integration of the lin-
earized plasmids, GSH1 gene of wt W303-1b was deleted 
or replaced by recombinant DNA fragment of S. cerevi-
siae PRO1 or E. coli proB, and the resulting strains were 
W303-1b/Δgsh1 (GSH1 deletion), W303-1b/Δgsh1/pro1 
(GSH1::Pgap-PRO1-Tpgk1) and W303-1b/Δgsh1/proB 
(GSH1::Pgap-proB-Tpgk1) (Table  2). Patch assay on YPD 
containing the given amounts of H2O2 was carried out 
with wt W303-1b, W303-1b/Δgsh1, W303-1b/Δgsh1/
pro1 and W303-1b/Δgsh1/proB to detect their H2O2 
Table 1 An overview of  literature on the production of GSH without addition of amino acid precursors by microorgan-
isms
Host strain Strategy GSH content 
in mutant
GSH content  
in wild type
References
C. utilis Classical selection 3–5 % 0.1–1 % [14]
S. cerevisiae
S. cerevisiae pGSR2518-x containing gshA of E. coli B fused with a S. cerevisiae promoter 
fragment P8 was used to transform S. cerevisiae YNN27
1.54 % 0.5 % [17]
S. cerevisiae A recombinant plasmid pGMF with GSH1 from S. cerevisiae was introduced 
into S. cerevisiae YSF-31
1.31 % 0.87 % [18]
S. cerevisiae Plasmids, pδAUR-GCS and pδAUR-GS, containing GSH1 and GSH2 from S. 
cerevisiae were linearized and integrated at δ-sites with high copy numbers 
into the ribosomal DNA of S. cerevisiae YPH499
1.51 % 1.03 % [19]
Sulfate assimilation metabolism and GSH synthetic metabolism were combi-
natorially engineered in S. cerevisiae YPH499
1.83 %
S. cerevisiae gshF derived from Streptococcus thermophilus was integrated at a high copy 
number into the ribosomal DNA of S. cerevisiae BY4741
54.9 μM/g DCW 
(1.69 %)
11.7 μM/g DCW 
(0.36 %)
[22]
P. pastoris An integrative expression vector, pGAPZHGSH, containing GSH1 and GSH2 
from S. cerevisiae regulated by GAP promoter was transformed into P. 
pastoris GS115
0.92 g (GSH)/L [16]
94.98 g (DCW)/L 
(0.97 %)
P. pastoris An integrative expression vector, pGAPZHGSH, containing GSH1 and GSH2 
from S. cerevisiae regulated by GAP promoter was transformed into P. 
pastoris GS115
<0.05 mM/g DCW 
(<1.54 %)
<0.02 mM/g DCW 
(<0.61 %)
[21]
An integrative expression vector, pGAPZH-Lmgsh, containing gshF from 
Listeria monocytogenes regulated by GAP promoter was transformed into 
P. pastoris GS115
<0.04 mM/g DCW 
(<1.23 %)
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tolerances that normally require GSH. As for W303-1b/
Δgsh1/pro1 or W303-1b/Δgsh1/proB, the overexpres-
sion of introduced Pro1 or ProB under the control of 
strong constitutive GAP promoter might allow a small 
amount of GSH in the host strains conferring tolerance 
to oxidative stress. As shown in Fig. 3, all transformants 
grew on the plates with the concentration of H2O2 below 
1.0  mM. However, their growth rates were apparently 
slower than wt strain (data not shown). W303-1b/Δgsh1 
and W303-1b/Δgsh1/proB failed to grow when addi-
tion of H2O2 was more than 1.5  mM, while W303-1b/
Δgsh1/pro1 with Pro1 overexpression construct afforded 
to form colonies on YPD containing 3.0 mM H2O2. The 
presence of GSH in W303-1b/Δgsh1/pro1 was about 4 % 
of wt level (Fig.  4c). This data showed that overexpres-
sion of Pro1 could produce more γ-glutamyl phosphate 
involved in an alternative pathway for a small amount of 
GSH formation in S. cerevisiae W303-1b. 
Overexpression of enzymes involved in GSH biosynthesis
In earlier studies, Gsh1 and Gsh2 (GshA and GshB) 
derived from yeast or E. coli were independently applied 
Table 2 Strains and plasmids used in this study
a W303-1b/F/GAP and W303-1b/F represent the same engineered strain in this study
Strains or plasmids Relevant properties Source or 
references
Strains
 E. coli Trans1-T1 F− ϕ80(lacZ) ΔM15 ΔlacX74 hsdR(rK− mK+) ΔrecA1398 endA1 tonA Our lab
 S. cerevisiae W303-1b MATα ade2-1 leu2-3,112 his3-11,15 ura3-1 trp1-1 Our lab
 W303-1b/Δgsh1 W303-1b derivative with pΔgsh1h, GSH1::HygB This study
 W303-1b/Δgsh1/pro1 W303-1b derivative with pΔgsh1h-pro1, GSH1::Pgap-PRO1-Tpgk1 This study
 W303-1b/Δgsh1/proB W303-1b derivative with pΔgsh1h-proB, GSH1::Pgap-proB-Tpgk1 This study
 W303-1b/F/GAP (W303-1b/F)a W303-1b derivative with pδGAPg-gshF This study
 W303-1b/F/GAP′ W303-1b derivative with pδGAP′g-gshF This study
 W303-1b/F/PGK1 W303-1b derivative with pδPGK1g-gshF This study
 W303-1b/F/GAL1 W303-1b derivative with pδGAL1g-gshF This study
 W303-1b/Δgsh1/F W303-1b/F derivative with pΔgsh1h, GSH1::HygB This study
 W303-1b/G W303-1b derivative with pδGAPh-gsh2gsh1 This study
 W303-1b/P W303-1b derivative with pδGAPg-pro1gshB This study
 W303-1b/P′ W303-1b derivative with pδGAPg-proBgshB This study
 W303-1b/FF W303-1b/F derivative with pδGAPg-gshF This study
 W303-1b/FG W303-1b/F derivative with pδGAPh-gsh2gsh1 This study
 W303-1b/FP W303-1b/F derivative with pδGAPg-pro1gshB This study
 W303-1b/FGP W303-1b/FG derivative with pδGAPg-pro1gshB This study
Plasmids
 pG pBluescript II KS(+) derivative with homologous region of GSH1 Our lab
 pΔgsh1h pBluescript II KS(+) derivative with homologous region of GSH1, HygBr This study
 pΔgsh1h-pro1 pG derivative with Pgap, PRO1, Tpgk1, HygB
r This study
 pΔgsh1h-proB pG derivative with Pgap, proB, Tpgk1, HygB
r This study
 pδGAPg pBluescript II KS(+) derivative with homologous δ region, Pgap, Tpgk1, G418r Our lab
 pδGAP′g pBluescript II KS(+) derivative with homologous δ region, Pgap′, Tpgk1, G418r Our lab
 pδPGK1g pBluescript II KS(+) derivative with homologous δ region, Ppgk1, Tpgk1, G418r Our lab
 pδGAL1g pBluescript II KS(+) derivative with homologous δ region, Pgal1, Tpgk1, G418r Our lab
 pδGAPh pBluescript II KS(+) derivative with homologous δ region, Pgap, Tpgk1, HygBr Our lab
 pδGAPg-gshF pδGAPg derivative with A. pleuropneumoniae gshF, G418r This study
 pδGAP′g-gshF pδGAP′g derivative with A. pleuropneumoniae gshF, G418r This study
 pδPGK1g-gshF pδPGK1 g derivative with A. pleuropneumoniae gshF, G418r This study
 pδGAL1g-gshF pδGAL1 g derivative with A. pleuropneumoniae gshF, G418r This study
 pδGAPh-gsh2gsh1 pδGAPh derivative with GSH2-GSH1 from S. cerevisiae, HygBr This study
 pδGAPg-pro1gshB pδGAPg derivative with PRO1-gshB from S. cerevisiae and E. coli, respectively, G418r This study
 pδGAPg-proBgshB pδGAPg derivative with proB-gshB from E. coli, G418r This study
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to various model microorganisms to generate genetically 
engineered strains with higher GSH productive capaci-
ties [15–19]. GshF from bacteria was also expressed in E. 
coli and yeast [20–22]. Here, A. pleuropneumoniae GshF 
was successfully expressed in S. cerevisiae as mentioned 
above. However, the recombinant constructs of Gsh2-
Gsh1 and Pro1-GshB with a flexible linker have not been 
exploited for improving intracellular GSH synthesis until 
now.
To evaluate the potential of different pathways 
geared toward improving GSH synthesis, several δ 
DNA-mediated integrative expression vectors pδGAPh-
gsh2gsh1, pδGAPg-pro1gshB or pδGAPg-proBgshB 
harbouring different pathway genes were constructed. 
Recombinant S. cerevisiae strains W303-1b/G, W303-
1b/P or W303-1b/P′ (Table  2) were then generated by 
transforming different linearized plasmids into S. cer-
evisiae W303-1b as constructed W303-1b/F. The path-
way genes with strong constitutive GAP promoters were 
introduced into the genome of W303-1b via homolo-
gous integration at δ-sites. To further compare GSH 
synthetic capacities of different pathways, GSH1 gene of 
engineered strain W303-1b/F was deleted to eliminate 
synthesis of GSH by endogenous enzymes. The result-
ing strain W303-1b/Δgsh1/F (F pathway) together with 
W303-1b/G (G pathway) and W303-1b/Δgsh1/pro1 (P 
pathway) represent different pathway strains (Table  2). 
No dramatic differences in biomass between W303-
1b/G, W303-1b/F, W303-1b/Δgsh1/F, W303-1b/P or 
W303-1b/P′ and original strain W303-1b were observed 
during shake flask cultures (Fig.  4). Three engineered 
strains W303-1b/G, W303-1b/F and W303-1b/P dis-
played higher activities for synthesizing GSH than the 
parental strain. The highest intracellular concentration 
of GSH was 186.77 mg/L produced by strain W303-1b/F, 
and most of the synthesized GSH could be attributed to 
the function of the introduced GshF as strain W303-1b/
Δgsh1/F yielded a similar amount (about 90 %) GSH to 
W303-1b/F. Other strains W303-1b/G, W303-1b/P and 
W303-1b produced 145.72, 111.82 and 98.75  mg/L of 
GSH, respectively. Results of the synthetic capacities of 
different pathways (ranked in descending order) are as 
follows: F pathway, G pathway and P pathway.
Fig. 2 Evaluation of synthetic capacities of GSH of engineered S. 
cerevisiae strains harbouring gshF gene under the control of four dif-
ferent promoters. Intracellular GSH amount was monitored after 24-h 
fermentation and measured every 12 h. The values are presented as 
the means, and the error bars show the SD (n = 3)
Fig. 3 Patch assay on YPD containing the indicated amounts of H2O2. The tolerances to H2O2 of W303-1b (wt), W303-1b/Δgsh1 (GSH1 deletion), 
W303-1b/Δgsh1/pro1 (GSH1::Pgap-PRO1-Tpgk1) and W303-1b/Δgsh1/proB (GSH1::Pgap-proB-Tpgk1) were evaluated
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Since W303-1b/F synthesized the highest GSH concen-
tration among tested strains, it was chosen to examine 
the effect of gene dosage on GSH production. The antibi-
otic-resistant gene was removed from the genomic DNA 
of W303-1b/F using the Cre-loxP system, then W303-
1b/F cells were further transformed with the linearized 
recombinant plasmid pδGAPg-gshF to obtain engineered 
strain W303-1b/FF (Table 2). Three recombinant strains 
harbouring two copies of gshF gene relative to that of 
W303-1b/F (Additional file  1: Table S8) were obtained 
and compared for their GSH production with W303-
1b/F. However, no further improvement was observed 
(Fig. 4). This result suggests that increasing copy number 
was shown to be effective up to a certain limit of gene 
copy number.
Three biosynthetic pathways combined to increase GSH 
production
To obtain a higher GSH concentration, three biosynthetic 
pathways of GSH were combinatorially expressed in S. 
cerevisiae W303-1b. Strain W303-1b/F with higher syn-
thetic capacity of GSH was chosen as the starting strain 
for further introduction of other biosynthetic pathways. 
The two-pathway strains W303-1b/FG and W303-1b/FP 
were obtained by the integration of linearized pδGAPh-
gsh2gsh1 and pδGAPg-pro1gshB, respectively. Further 
integration of linearized pδGAPg-pro1gshB into the engi-
neered W303-1b/FG generated the three-pathway strain 
W303-1b/FGP (Table 2).
As expected, strains W303-1b/FG, W303-1b/FP and 
W303-1b/FGP yielded 206.70, 190.57 and 216.50 mg/L of 
GSH in shake flask cultures, indicating that introduction 
of a second pathway could enhance the synthetic capac-
ity of GSH. Among all the engineered strains, the strain 
W303-1b/FGP with three biosynthetic pathways showed 
the highest GSH producing capacity and improved the 
intracellular GSH concentration by 2.19-fold compared 
with W303-1b (Table 3; Fig. 5).
Shake flask culture with addition of amino acid precursors
Genetic manipulation and medium optimization together 
with the addition of amino acid precursors are required 
◂ Fig. 4 Single modulation of G pathway, F pathway and P pathway 
for GSH biosynthesis in S. cerevisiae. a GSH concentration (mg/L). 
b Biomass (DCW). c GSH content (%). G (F or FF, P or P′) represents 
improvement of GSH amount conferred by the overexpression of 
G (F, P or P′) pathway and H represents GSH amount of host strain 
W303-1b. DCW is calculated from OD600 values (OD600 = 10 corre-
sponds to 1.19 g/L DCW). The values are presented as the means, and 
the error bars show the SD (n = 3)
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to increase GSH production. In order to further investi-
gate the potential of three-pathway combinatorial biosyn-
thesis of GSH, we compared utilization and conversion 
efficiency of amino acid precursors of engineered strain 
W303-1b/FGP with that of strain W303-1b/F in shake 
flask cultures. Figure 6 showed that the biomass of both 
W303-1b/FGP and W303-1b/F dropped by around 10 % 
when three amino acid precursors were added, and GSH 
contents of W303-1b/FGP and W303-1b/F were 3.77 and 
2.94 %, respectively. After addition of amino acid precur-
sors, GSH production of W303-1b/FGP was improved by 
61.37 %, while that of W303-1b/F was 43.17 %. This result 
indicated that the engineered strain W303-1b/FGP held a 
higher utilization and conversion efficiency of amino acid 
precursors. That is to say, advantages of W303-1b/FGP 
over W303-1b/F include higher GSH yield and utilization 
and conversion efficiency of amino acid precursors.
Batch culture of engineered strain with three biosynthetic 
pathways
To examine the GSH productive capacity of engineered 
strain W303-1b/FGP in a larger scale, batch cultivation 
for GSH production was carried out in a 10-L fermen-
tor. The time course of batch culture with W303-1b/
FGP was shown in Fig.  7. Both GSH concentration and 
biomass were higher than that of shake flask culture. 
The GSH concentration increased to the highest point 
of 272.52 mg/L after fermentation for 24 h, and the GSH 
content was 2.27  %. It was observed that the GSH pro-
ductive capacity measured by GSH content showed no 
obvious change after scale-up fermentation.
Discussion
Recently, a novel bifunctional enzyme GshF has aroused 
concerns about GSH productive capacity as most 
reported GshFs are insensitive to feedback inhibition of 
GSH except that of P. multocida and L. monocytogenes 
[8–11, 20]. In this study, the putative gshF from A. pleu-
ropneumoniae resynthesized according to codon usage of 
S. cerevisiae was firstly functionally expressed in S. cer-
evisiae, and then the relationship between GSH produc-
tion and the strengths of three different glucose-based 
promoters, including GAP and PGK1 promoters of S. 
cerevisiae and GAP promoter from P. pastoris (GAP′), 
and a galactose-based GAL1 promoter of S. cerevisiae 
was analyzed. Figure 2 showed that the expressed GshF 
under the control of constitutive GAP promoter of S. cer-
evisiae produced the highest concentration of GSH. Thus 
it is presumed that the expression of GshF driven by GAP 
promoter of S. cerevisiae functioned well for GSH synthe-
sis. Through the comparison of the productive capacity 
of GSH of engineered strain W303-1b/F with that of the 
reported GS115/LmgshF with L. monocytogenes GshF, an 
observed variance was that F pathway presented higher 
synthetic capacity of GSH than G pathway (Fig. 4) [21]. 
This conflicting result may be attributed to the differ-
ent sensitivities of GshFs from L. monocytogenes and A. 
pleuropneumoniae to feedback inhibition of GSH [8, 11]. 
Since single F pathway could produce higher amounts 
of GSH compared with other pathways, we tried to aug-
ment the copies of F pathway by further integration of 
gshF to improve the productive capacity of GSH of engi-
neered strain W303-1b/F. However, the gshF copy num-
ber increase didn’t further improve GSH concentration in 
W303-1b/F, indicating that a reasonable rather than high 
copy number of gshF gene driven by GAP promoter is 
sufficient for the highest expression levels and synthetic 
capacity of GSH through one pathway is limited.
It has been reported that proline biosynthesis could 
contribute to GSH synthesis. γ-glutamyl phosphate is 
Table 3 Biomass, GSH concentration, GSH content and  molar ratio of  γ-GC to  GSH of  various strains in  flask cultures 
with or without addition of amino acid precursors (AA)
a DCW is calculated from OD600 values (OD600 = 10 corresponds to 1.19 g/L DCW). The values given are mean values ± standard deviation
Strains Biomass  
(DCW)a
GSH concentration  
(mg/L)
GSH content  
(%)
Molar ratio of  
γ‑GC to GSH (%)
W303-1b 9.14 ± 0.48 98.75 ± 7.30 1.09 ± 0.14 6.74 ± 0.24
W303-1b/F 9.09 ± 0.13 186.77 ± 3.19 2.05 ± 0.06 10.29 ± 0.87
W303-1b/G 9.56 ± 0.26 145.72 ± 14.87 1.52 ± 0.14 9.72 ± 0.93
W303-1b/P 9.23 ± 0.32 111.82 ± 11.34 1.21 ± 0.09 8.58 ± 2.53
W303-1b/P′ 8.74 ± 0.44 104.24 ± 9.86 1.19 ± 0.08 7.34 ± 0.42
W303-1b/FG 9.35 ± 0.38 206.70 ± 7.23 2.21 ± 0.02 11.26 ± 0.67
W303-1b/FP 9.04 ± 0.20 190.57 ± 1.56 2.11 ± 0.05 10.92 ± 0.93
W303-1b/FGP 9.26 ± 0.07 216.50 ± 11.46 2.34 ± 0.13 9.97 ± 0.40
W303-1b/F (AA) 8.58 ± 0.09 252.33 ± 28.62 2.94 ± 0.36 9.65 ± 0.51
W303-1b/FGP (AA) 8.38 ± 0.37 316.77 ± 45.69 3.77 ± 0.43 9.50 ± 1.43
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required as the common intermediate for the crosstalk 
between proline biosynthetic pathway and conven-
tional Gsh1/Gsh2 pathway. Veeravalli et  al. reported 
that, different from in vitro assay, as l-cysteine is pre-
sent in micromolar concentrations in the intracellu-
lar environment, the activity of γ-glutamyl phosphate 
reductase (GPR) encoded by PRO2 in eukaryotes or 
proA in prokaryotes must be shut off to allow γ-GC 
formation from γ-glutamyl phosphate [12]. In this 
study, as amino acid precursors could be fed to 
improve concentrations of intracellular free l-cysteine, 
we resorted to overexpression of GK instead of loss-
of-function mutations in GPR for accumulation of 
γ-glutamyl phosphate to strengthen the redirec-
tion of γ-glutamyl phosphate to GSH synthesis. It 
was indirectly confirmed by the result of patch assay 
that W303-1b/Δgsh1/pro1 with Pro1 overexpres-
sion construct performed a relatively stronger H2O2 
tolerance than W303-1b/Δgsh1/proB and W303-1b/
Δgsh1 (Fig.  3). Overexpressed Pro1 mediated accu-
mulation of γ-glutamyl phosphate which was partially 
diverted toward GSH production, while heterologous 
ProB (optimized according to codon usage of S. cer-
evisiae) did not work well. Consistent with the result 
of patch assay, W303-1b/P provided a slightly higher 
GSH production than W303-1b/P′ and strain W303-1b 
in shake flask cultures (Fig.  4). When P pathway was 
upregulated, the accumulated γ-glutamyl phosphate 
could improve utilization of extra l-cysteine by addi-
tion of amino acid precursors for improvement of GSH 
synthesis. Thus, P pathway could be modulated for 
improving intracellular GSH synthesis.
Previous studies have reported individual modula-
tion of G pathway and F pathway for GSH produc-
tion [15–22]. In this study, P pathway was exploited for 
GSH production for the first time. Combining G, F and 
P three pathways is a novel method for GSH produc-
tion. Genes of three pathways were uniformly regulated 
and expressed by exactly the same strategy to evalu-
ate synthetic capacities of engineered strains with dif-
ferent combinations of biosynthetic pathways of GSH. 
As expected, the engineered strain W303-1b/FGP pre-
sented the highest yield of GSH. Moreover, the result of 
shake flask cultures with addition of amino acid precur-
sors (Fig. 6) further proved the advantages of W303-1b/
FGP. In batch culture process, the recombinant strain 
W303-1b/FGP also afforded high efficiency in GSH pro-
duction and reached an intracellular GSH content of 
2.27 % after 24-h fermentation. Generally, a GSH content 
of 3–5 % could be obtained using strains selected via clas-
sical selection strategy, but the exact mechanisms under-
lying higher GSH accumulation in these mutants has 
remained rather obscure. Nisamedtinov et  al. reported 
Fig. 5 GSH production of single-pathway, two-pathway and three-
pathway engineered strains. a GSH concentration (mg/L). b Biomass 
(DCW). c GSH content (%). G (F, P or P′) represents improvement 
of GSH amount conferred by the overexpression of G (F, P or P′) 
pathway and H represents GSH amount of host strain W303-1b. DCW 
is calculated from OD600 values (OD600 = 10 corresponds to 1.19 g/L 
DCW). The values are presented as the means, and the error bars 
show the SD (n = 3)
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that GSH over-accumulation in S. cerevisiae mutants 
selected via random mutagenesis is caused by the com-
bined effect of higher cysteine synthesis and increased 
flux through Gsh1 reaction [25]. These genetic manipula-
tions could confer a GSH content of 1–2 % on the engi-
neered strains. The GSH synthetic capacity of engineered 
strain W303-1b/FGP constructed in this study was 
comparable to that of reported genetically engineered 
strains and higher than that of engineered strains with 
single modulation of G pathway or F pathway (Table 1). 
Increase in GSH content of W303-1b/FGP may be attrib-
uted to the fact that the three pathways form a complex 
network of GSH biosynthesis producing comprehensive 
effects. Here, it should be noted that the balance of two 
consecutive enzymatic reactions especially in the com-
plex network of GSH biosynthesis is very important. 
Previous studies have reported that overexpression of 
conventional Gsh1/Gsh2 pathway improved production 
of intracellular GSH along with accumulation of inter-
mediate γ-GC which increased significantly when amino 
acid precursors were added [21]. In our study, as the 
intracellular γ-GC level was only increased slightly com-
pared with that of original strain W303-1b when F path-
way was introduced, we artificially introduced a flexible 
six-glycine linker between the two enzymes of G pathway 
as well as P pathway to improve the coupling efficiency 
by mimicking the native domain fusion of GshF. As 
expected, intracellular γ-GC amounts of W303-1b/FGP 
were still maintained at low levels even when amino acid 
precursors were added (Table 3).
Conclusions
In summary, a three-pathway combinatorial method of 
GSH biosynthesis presents higher GSH yield and utili-
zation efficiency of amino acid precursors than that of 
a single pathway. This strategy is an important develop-
ment toward improving industrial production of GSH 
using S. cerevisiae.
Fig. 6 Evaluation of synthetic capacities of GSH of engineered S. 
cerevisiae W303-1b/F and W303-1b/FGP in shake flask cultures with or 
without addition of three amino acid precursors. a GSH concentration 
(mg/L). b Biomass (DCW). c GSH content (%). G (F or P) represents 
improvement of GSH content conferred by overexpression of G (F 
or P) pathway, H represents GSH content of host strain W303-1b and 
AA indicates improvement of GSH amount conferred by addition 
of amino acid precursors. DCW is calculated from OD600 values 
(OD600 = 10 corresponds to 1.19 g/L DCW). The values are presented 
as the means, and the error bars show the SD (n = 3)
◂
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Methods
Strains
E. coli Trans1-T1 (TransGen, Beijing, China) was used 
for propagation and manipulation of the recombinant 
DNA. S. cerevisiae W303-1b (MATα ade2-1 leu2-3,112 
his3-11,15 ura3-1 trp1-1) was used as host strain for 
DNA transformation and expression of recombinant 
genes. Yeast transformants were grown at 30  °C in YPD 
medium (10 g/L yeast extract, 20 g/L tryptone and 20 g/L 
glucose).
Plasmid construction and yeast transformation
All plasmids were constructed using conventional restric-
tion enzyme-mediated cloning methods. Based on the 
nucleotide sequences of the target genes, development of 
primer sets were designed and used to amplify gene frag-
ments by PCR (Additional file 1: Tables S1–S6). δ DNA-
mediated integrative expression vectors as described 
in Ref. [26], and plasmids for deletion of GSH1 gene 
were constructed as shown in Additional file  1: Figures 
S1–S4. The resulting plasmids were linearized by diges-
tion with restriction enzyme NotI and transformed into 
S. cerevisiae using lithium acetate method. The positive 
transformants were selected on YPD plates with addition 
of antibiotics geneticin (G418, 4  mg/mL) or hygromy-
cin B (HygB, 1 mg/mL) and verified by DNA sequencing 
after the integrated gene fragments were amplified by 
PCR using the corresponding primers and the genomic 
DNA templates. The copy numbers of integrated genes 
were verified using real-time PCR (primers GshF-RT1/
GshF-RT2, Additional file 1: Table S7) and calculated by 
a comparative CT method [27]. For each transformation, 
three positive colonies were picked randomly for further 
investigation. The repeated use of the marker genes were 
performed via a loxP-marker-loxP gene disruption cas-
sette according to Ref. [28].
Patch assay
Single colonies of strains W303-1b, W303-1b/Δgsh1, 
W303-1b/Δgsh1/pro1 and W303-1b/Δgsh1/proB were 
diluted in distilled H2O and patched (about 500 cells/
μL) on YPD plates containing various concentrations of 
H2O2. Plates were incubated for about 72  h at 30  °C to 
compare H2O2 tolerances by watching their growth.
GSH production of the engineered S. cerevisiae strains 
in shake flasks
Three positive colonies of each engineered S. cerevisiae 
strain were cultured at 30  °C in shake flasks containing 
20 mL of liquid YPD medium with agitation at 250 rpm 
for 18–24 h for primary culture. An adequate volume of 
fresh cultures were then inoculated into a set of 250-mL 
flasks containing 50  mL of liquid YPD medium to keep 
an initial optical density at 600 nm (OD600) value of 0.2. 
The cultures were incubated at 30  °C with agitation at 
250 rpm for additional 48 h. In order to further increase 
the production of GSH, the addition of amino acid pre-
cursors (5 mM glutamic acid, 5 mM cysteine and 5 mM 
glycine) was single shot after 36-h cultivation for feeding 
assay.
Fig. 7 Batch culture of S. cerevisiae W303-1b/FGP in 10-L fermentor. The working volume was 4 L. Culture temperature and DO were controlled at 
30 °C and 25 %, and pH was uncontrolled. Intracellular GSH amount was measured every 8 h
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Batch culture of the engineered strain W303‑1b/FGP 
for GSH production
The batch fermentation was operated in a 10-L fermentor 
(China Beauty). Liquid YPD medium for batch culture 
was sterilized by autoclave at 121  °C for 20  min. Engi-
neered strain W303-1b/FGP grown on YPD agar plate 
was inoculated into liquid YPD medium and cultured at 
30  °C with agitation at 250 rpm for 18–24 h. 10 % (v/v) 
seed cultures were transferred into the fermentor. The 
dissolved oxygen (DO) was maintained at 25 % through 
adjustment of stirrer speed (100–500 rpm) and the aera-
tion rate (1–5 L/h). The temperature was set to 30 °C and 
the pH was uncontrolled.
Analytical methods
Grown cultures were removed from the incubator at a 
given time and biomass was measured as optical density 
at 600  nm (OD600) and/or the dry cell weight (DCW). 
OD600 was determined after the sample was appropriately 
diluted. DCW (g/L) was determined after yeast cells were 
centrifuged at 4000 rpm for 10 min and washed twice with 
distilled water before drying at 105 °C to constant weight. 
OD600 was converted to DCW using calibration coefficient 
(OD600 = 10, equivalent to 1.19 g/L DCW in this study). 
To monitor the intracellular GSH and γ-GC amounts, cells 
were harvested and washed with distilled water. Intracel-
lular GSH and γ-GC were extracted from the cells by 40 % 
ethanol for 2 h at 30  °C. The GSH and γ-GC concentra-
tions (mg/L) of the sample were measured using the 
4-fluoro-7-aminosulfonylbenzofurazan (ABD-F) derivati-
zation method (Additional file 1: Figure S5) according to 
a previous report [29] with the reduced GSH as the stand-
ard. The GSH content (%) was calculated from the intracel-
lular GSH concentration (mg/L) divided by DCW.
Additional file
Additional file 1. Table S1. Primers used for cloning of A. pleuropneu-
moniae gshF gene optimized according to codon usage of S. cerevisiae. 
Table S2. Primers used for cloning of S. cerevisiae GSH2 gene. Table S3. 
Primers used for cloning of S. cerevisiae GSH1 gene. Table S4. Primers used 
for cloning of S. cerevisiae PRO1 gene. Table S5. Primers used for cloning 
of E. coli proB mutant optimized according to codon usage of S. cerevisiae. 
Table S6. Primers used for cloning of E. coli gshB mutant optimized 
according to codon usage of S. cerevisiae. Table S7. Primers used for 
real-time PCR to verify copy number of gshF gene. Table S8. Relative 
quantitation of copy number of gshF gene. Figure S1. Construction of 
integrative expression vectors pδGAPg-gshF, pδGAP′g-gshF, pδGAL1g-
gshF and pδPGK1g-gshF used to evaluate effects of different promoter 
strengths on the activity of GshF. Figure S2. Construction of integrative 
expression vector pδGAPh-gsh2gsh1 for overexpression of Gsh2-Gsh1 
fusion protein. Figure S3. Construction of integrative expression vectors 
pδGAPg-pro1gshB and pδGAPg-proBgshB for overexpression of Pro1-GshB 
and ProB-GshB fusion proteins. Figure S4. Construction of plasmids 
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with ABD-F.
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